EMEA-002033-PIP01-16

Key facts

Invented name
Active substance
Vosoritide (BMN 111)
Therapeutic area
Other
Decision number
P/0379/2017
PIP number
EMEA-002033-PIP01-16
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of achondroplasia
Route(s) of administration
Subcutaneous use
Contact for public enquiries
BioMarin International Limited
Tel. +44 2074200800
E-mail: biomarin-europe@bmrn.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating